George Somlo Selected Research

George Somlo Research Topics

Disease

66	Neoplasms (Cancer) 01/2022 - 11/2002
63	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2002
24	Multiple Myeloma 01/2022 - 11/2003
8	Triple Negative Breast Neoplasms 01/2022 - 01/2015
6	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2007
5	Pathologic Complete Response 01/2022 - 06/2013
5	Disease Progression 01/2019 - 12/2011
4	Circulating Neoplastic Cells 01/2022 - 09/2009
4	Leukemia 12/2019 - 02/2003
4	Peripheral Nervous System Diseases (PNS Diseases) 10/2012 - 01/2004
3	Nausea 08/2017 - 02/2007
3	Thrombocytopenia (Thrombopenia) 08/2017 - 02/2003
3	Lymphoma (Lymphomas) 10/2015 - 05/2005
3	Infections 01/2015 - 07/2006
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2013 - 02/2003
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2013 - 05/2008
3	Sarcoma (Soft Tissue Sarcoma) 08/2010 - 09/2004
2	Carcinogenesis 01/2020 - 01/2013
2	Inflammatory Breast Neoplasms 01/2018 - 05/2004
2	Fatigue 08/2015 - 09/2007
2	Bronchiolitis Obliterans Syndrome 08/2014 - 04/2005
2	Lung Neoplasms (Lung Cancer) 01/2013 - 09/2009
2	Vomiting 07/2012 - 02/2007

Drug/Important Bio-Agent (IBA)

10	Estrogen ReceptorsIBA 12/2021 - 05/2004
9	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 10/2004
9	Hormones (Hormone)IBA 01/2022 - 04/2013
9	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2008
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2004
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2004
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2005
7	MicroRNAs (MicroRNA)IBA 02/2016 - 08/2009
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2004
6	Bortezomib (Velcade)FDA Link 01/2019 - 01/2009
6	Trastuzumab (Herceptin)FDA Link 01/2016 - 03/2006
5	Bevacizumab (Avastin)FDA Link 01/2022 - 08/2011
5	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 03/2012
5	Gemcitabine FDA Link 01/2010 - 11/2002
4	RNA (Ribonucleic Acid)IBA 12/2021 - 03/2012
4	Lenalidomide (CC 5013)FDA Link 11/2021 - 02/2013
4	130-nm albumin-bound paclitaxelIBA 01/2021 - 01/2015
4	PlatinumIBA 01/2021 - 11/2002
4	Interleukin-6 (Interleukin 6)IBA 10/2017 - 12/2010
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2005
3	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 01/2009
3	Estrogens (Estrogen)FDA Link 12/2021 - 07/2011
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2018
3	Pharmaceutical PreparationsIBA 04/2019 - 01/2013
3	human ERBB2 proteinIBA 01/2019 - 08/2010
3	Biological ProductsIBA 06/2018 - 08/2010
3	Docetaxel (Taxotere)FDA Link 01/2018 - 12/2003
3	Monoclonal AntibodiesIBA 11/2015 - 12/2009
3	CytokinesIBA 08/2015 - 06/2012
3	Progesterone Receptors (Progesterone Receptor)IBA 04/2014 - 05/2004
3	ErbB Receptors (EGF Receptor)IBA 02/2014 - 09/2009
3	carfilzomibIBA 10/2012 - 06/2011
3	Thalidomide (Thalomid)FDA Link 03/2012 - 09/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2009 - 01/2005
3	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2009 - 01/2005
2	Everolimus FDA Link 01/2022 - 08/2018
2	pomalidomideIBA 11/2021 - 07/2018
2	LeptinIBA 01/2020 - 01/2018
2	Phosphotransferases (Kinase)IBA 04/2019 - 12/2010
2	palbociclibIBA 04/2019 - 06/2018
2	sapanisertibIBA 04/2019 - 08/2018
2	trans-crotonin (CTN)IBA 01/2019 - 12/2011
2	Aromatase InhibitorsIBA 08/2018 - 03/2006
2	Vorinostat FDA Link 01/2018 - 11/2008
2	fibrin fragment D (D-dimer)IBA 10/2017 - 08/2017
2	Blood Coagulation Factors (Coagulation Factor)IBA 10/2017 - 08/2017
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2017 - 11/2014
2	veliparibIBA 08/2017 - 11/2014
2	Phenobarbital (Luminal)FDA Link 01/2017 - 01/2013
2	Filgrastim (Neupogen)FDA Link 10/2015 - 01/2014
2	AnthracyclinesIBA 02/2015 - 07/2012
2	taxaneIBA 02/2015 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 11/2014 - 09/2009
2	Vinorelbine (Navelbine)FDA LinkGeneric 04/2014 - 01/2014
2	Dasatinib (BMS 354825)FDA Link 06/2013 - 04/2013
2	Capecitabine (Xeloda)FDA Link 04/2013 - 11/2009
2	Proteasome InhibitorsIBA 10/2012 - 10/2012
2	Imatinib Mesylate (Gleevec)FDA Link 08/2010 - 02/2010
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 11/2009 - 05/2008
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2009 - 03/2007

Therapy/Procedure

40	Therapeutics 01/2022 - 11/2003
29	Drug Therapy (Chemotherapy) 01/2019 - 06/2003
11	Neoadjuvant Therapy 01/2022 - 01/2012
9	Cell Transplantation 12/2019 - 11/2003
8	Stem Cell Transplantation 08/2014 - 02/2003
6	Adjuvant Chemotherapy 12/2018 - 09/2009
6	Radiotherapy 01/2017 - 05/2004
4	Transplantation 01/2019 - 06/2003
3	Autologous Transplantation 01/2022 - 08/2009
3	Biological Therapy 03/2016 - 04/2014
3	Salvage Therapy 01/2013 - 04/2005
3	Homologous Transplantation 01/2013 - 02/2003
2	Aftercare (After-Treatment) 01/2018 - 09/2009
2	Immunotherapy 01/2018 - 02/2003
2	Segmental Mastectomy (Lumpectomy) 01/2016 - 09/2015
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 03/2012 - 11/2005
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2011 - 01/2009